Distinct fibrosis-associated macrophage subsets coordinate iron metabolism in pulmonary fibrosis
- 24 April 2026
- journal article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 38 (8) , 521-534
Abstract
Pulmonary fibrosis has a poor prognosis due to challenges in early diagnosis and therapeutic intervention. Current treatments remain largely ineffective due to an incomplete understanding of the complex pathology, including the interactions between fibroblasts and profibrotic immune cells within fibrotic lungs. To elucidate the dynamics of fibrosis, we performed single-cell RNA sequencing (scRNA-seq) on bronchoalveolar lavage fluid (BALF) obtained from patients with interstitial lung disease (ILD). We identified the SPP1- and APOE-expressing macrophage population that is commonly present across ILDs. Histological analysis showed that this macrophage population accumulated at the center of fibrotic foci. Furthermore, the ratio of this macrophage population was increased in both progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF). Transcriptomic analysis further divided this macrophage population into two subsets: SLC40A1+ or HAMP+ fibrosis-associated macrophages. We found that the relative balance of IL-10 and IL-8 regulated SLC40A1 and HAMP expression within fibrosis-associated macrophages. Additionally, histological analysis revealed that bronchial epithelium expressed IL-8, while type II alveolar epithelial cells expressed IL-10 in the fibrotic lung. SLC40A1+ fibrosis-associated macrophages localized to CD31+ perivascular regions and mediated the uptake and degradation of the hemoglobin–haptoglobin complex. This dual pathway—providing iron via SLC40A1 and intracellular iron accumulation via HAMP—facilitated the transition of fibroblasts into SPP1+ myofibroblasts. Moreover, ferroptotic fibroblasts secreted TGF-β1, which further contributes to fibrotic progression. In conclusion, aberrant iron metabolism orchestrated by fibrosis-associated macrophages may contribute to fibrosis by facilitating the transition of myofibroblasts. These findings provide mechanistic insight into the progression of autonomous pulmonary fibrosis.Keywords
Funding Information
- Japan Intractable Diseases Research Foundation (2020B02)
- Otsuka Pharmaceutical (1851010012)
This publication has 49 references indexed in Scilit:
- Iron scavenging and myeloid cell polarizationTrends in Immunology, 2024
- Targeting iron-metabolism:a potential therapeutic strategy for pulmonary fibrosisBiomedicine & Pharmacotherapy, 2024
- Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent mannerCell Reports, 2023
- CNS border-associated macrophages in the homeostatic and ischaemic brainPharmacology & Therapeutics, 2022
- Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancerCell, 2022
- Integrated analysis of multimodal single-cell dataCell, 2021
- A cellular and spatial map of the choroid plexus across brain ventricles and agesCell, 2021
- Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of FibrosisImmunity, 2020
- Critical role for iron accumulation in the pathogenesis of fibrotic lung diseaseThe Journal of Pathology, 2020
- Two to Tango: Regulation of Mammalian Iron MetabolismCell, 2010